Domača stranKLBF • IDX
add
Kalbe Farma Tbk PT
Prejšnji trg. dan.
1535,00 Rp
Dnevni razpon
1510,00 Rp - 1555,00 Rp
Letni razpon
985,00 Rp - 1795,00 Rp
Tržna kapitalizacija
71,62 bil. IDR
Povprečni obseg
47,91 mio.
Razm. P/E
20,95
Dividendna donosnost
2,35 %
Primarna borza
IDX
Borzne novice
Finančni podatki
Izkaz poslovnega izida
Prihodek
Čisti dohodek
| (IDR) | mar. 2025info | Sprememba L/L |
|---|---|---|
Prihodek | 8,85 bil. | 5,77 % |
Stroški poslovanja | 2,24 bil. | 9,58 % |
Čisti dohodek | 1,08 bil. | 12,45 % |
Čista dobičkovnost prihodkov | 12,17 | 6,29 % |
Earnings per share | 23,57 | 13,86 % |
EBITDA | 1,57 bil. | 11,60 % |
Efektivna davčna stopnja | 22,83 % | — |
Bilanca stanja
Skupna sredstva
Skupne obveznosti
| (IDR) | mar. 2025info | Sprememba L/L |
|---|---|---|
Denar. in kratkor. naložbe | 4,69 bil. | 10,74 % |
Skupna sredstva | 30,58 bil. | 5,59 % |
Skupne obveznosti | 5,22 bil. | 7,63 % |
Celoten lastniški kapital | 25,36 bil. | — |
Shares outstanding | 45,65 mrd. | — |
Razmerje P/B | 2,98 | — |
Donosnost sredstev | 11,54 % | — |
Donosnost kapitala | 13,57 % | — |
Denarni tok
Neto sprememba denarnih sredstev
| (IDR) | mar. 2025info | Sprememba L/L |
|---|---|---|
Čisti dohodek | 1,08 bil. | 12,45 % |
Denar iz dejavnosti | 344,56 mrd. | −71,44 % |
Denar iz naložb | −118,66 mrd. | 61,24 % |
Denar iz financiranja | −423,13 mrd. | −791,88 % |
Neto sprememba denarnih sredstev | −180,46 mrd. | −121,28 % |
Prost denarni tok | −102,67 mrd. | −114,36 % |
Vizitka
PT Kalbe Farma Tbk, or simply known as Kalbe, is an Indonesian pharmaceutical, healthcare and nutrition company established in 1966. The company has expanded by strategic acquisitions of pharmaceutical companies, becoming an integrated consumer health and nutrition enterprise.
The Kalbe Group has brands in the prescription drugs, OTC drugs, energy drink and nutrition products, distribution arm that reaches over 1 million outlets. Notably, the company produces misoprostol, a drug which is used to treat stomach ulcers but is also widely used in Indonesia as an illegal abortifacient.
Company brands in healthcare and pharmaceutical segments include Promag, Mixagrip, Woods, Komix, Diabetasol, Prenagen, Extra Joss and Fitbar.
Kalbe is the largest publicly listed pharmaceutical company in Southeast Asia with around US$5 billion in market capitalization and revenues of over Rp 15 trillion. The name "Kalbe" is a syllabic abbreviation of its founder's name: Khouw Lip Boen. Wikipedia
Datum ustanovitve
10. sep. 1966
Spletno mesto
Zaposleni
12.841
